The company shifted from issuing FY 2027 guidance in Q4 to raising it in Q1; CEO Christopher Simon moved from “projected revenue growth of 4% to 7% reported” (Q4 FY 2026) to “raising our full year ...

Management’s fiscal 2027 guidance included: Hourican said, “We expect to deliver revenue growth of 6% to 7% for the year,” and “through disciplined margin and expense management, we expect to deliver ...

Vadzo Imaging has completed validation of Quad Shutter Control on the Innova-900MGS, its Sony Pregius S IMX900 Gigabit Ethernet Camera, confirming that all four independently configurable exposure ...

Snapchat will stop recommending fully AI generated videos on Spotlight, favoring authentic human made content instead, while ...

Rhythm Pharmaceuticals (NASDAQ:RYTM) released second-quarter financial results and hosted an earnings call on Tuesday. Read ...

U.S. launch of IMCIVREE® (setmelanotide) for acquired hypothalamic obesity (HO) starts strong with more than 400 patient start forms since FDA ...

The recognition of sepsis remains a challenge for emergency medicine: it requires deciding, at the bedside and with ...

Background Sepsis and infection are distinct yet overlapping conditions in the intensive care unit (ICU), posing diagnostic ...

Earnings call Post Holdings delivered Q1 FY26 adjusted EBITDA well above expectations, prompting a significant increase in full-year guidance. Strong Foodservice performance, continued aggressive ...